SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-030926
Filing Date
2023-11-08
Accepted
2023-11-08 16:00:28
Documents
41
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q govx20230930_10q.htm   iXBRL 10-Q 497832
2 EXHIBIT 31.1 ex_590328.htm EX-31.1 13608
3 EXHIBIT 31.2 ex_590329.htm EX-31.2 13392
4 EXHIBIT 32.1 ex_590330.htm EX-32.1 5218
5 EXHIBIT 32.2 ex_590331.htm EX-32.2 5244
  Complete submission text file 0001437749-23-030926.txt   2223594

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA govx-20230930.xsd EX-101.SCH 22603
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20230930_def.xml EX-101.DEF 139052
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20230930_lab.xml EX-101.LAB 135892
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20230930_pre.xml EX-101.PRE 153315
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE govx-20230930_cal.xml EX-101.CAL 24657
35 EXTRACTED XBRL INSTANCE DOCUMENT govx20230930_10q_htm.xml XML 203375
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39563 | Film No.: 231387647
SIC: 2834 Pharmaceutical Preparations